FLAVIVIRUS Mechanism and in vivo activity of novel glycan-based therapy against flavivirus endothelial permeability and vascular leak Evaluation of therapeutics targeting SARS-CoV-2 infection and defining pathogenic mechanisms of SARS-CoV-2-triggered pulmonary dysfunction NIAID/NIH R21 AI146464 Duration: 2020-2022 Role of Cyclolab: partner organization